Bessemer Group Inc Dexcom Inc Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Dexcom Inc stock. As of the latest transaction made, Bessemer Group Inc holds 963,908 shares of DXCM stock, worth $77.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

963,908

Previous 948,954 1.58%

Holding current value

$77.2 Million

Previous $108 Million 39.94%

% of portfolio

0.11%

Previous 0.19%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $957,056 - $1.74 Million	14,954 Added 1.58%	963,908 $64.6 Million
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $684,694 - $871,773	-6,207 Reduced 0.65%	948,954 $108 Million
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $42.5 Million - $52.1 Million	-372,228 Reduced 28.04%	955,161 $132 Million
Q4 2023 Feb 09, 2024	BUY	$75.49 - $124.16 $21.5 Million - $35.4 Million	285,136 Added 27.36%	1,327,389 $165 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $185,889 - $297,928	2,160 Added 0.21%	1,042,253 $97.2 Million
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $2.82 Million - $3.28 Million	25,061 Added 2.47%	1,040,093 $134 Million
Q1 2023 May 10, 2023	BUY	$104.0 - $122.92 $998,712 - $1.18 Million	9,603 Added 0.96%	1,015,032 $118 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $1.97 Million - $2.84 Million	23,173 Added 2.36%	1,005,429 $114 Million
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $2.4 Million - $2.96 Million	31,443 Added 3.31%	982,256 $79.1 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $45 Million - $88 Million	662,198 Added 229.44%	950,813 $70.9 Million
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $3.04 Million - $4.2 Million	32,280 Added 12.59%	288,615 $148 Million
Q4 2021 Jan 27, 2022	BUY	$129.87 - $162.82 $64,805 - $81,247	499 Added 0.2%	256,335 $138 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $11,631 - $15,606	109 Added 0.04%	255,836 $140 Million
Q2 2021 Aug 06, 2021	BUY	$80.99 - $107.93 $1.88 Million - $2.51 Million	23,253 Added 10.0%	255,727 $109 Million
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $3.75 Million - $4.63 Million	44,250 Added 23.51%	232,474 $20.9 Million
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $7,254 - $9,718	-93 Reduced 0.05%	188,224 $69.6 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $8.23 Million - $9.73 Million	86,118 Added 84.27%	188,317 $77.6 Million
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $6.41 Million - $10.8 Million	102,199 New	102,199 $41.4 Million
Q1 2020 Apr 30, 2020	SELL	$47.79 - $75.63 $0 - $0	0 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$36.62 - $57.29 $0 - $0	0 New	0 $0
Q2 2019 Jul 19, 2019	SELL	$27.84 - $38.92 $835 - $1,167	-30 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$28.07 - $38.18 $477 - $649	-17 Reduced 36.17%	30 $4,000
Q3 2018 Nov 06, 2018	BUY	$23.35 - $36.72 $1,097 - $1,725	47 New	47 $7,000
Q4 2017 Jan 30, 2018	SELL	$11.12 - $15.38 $2,946 - $4,075	-265 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$11.36 - $18.98 $3,010 - $5,029	265	265 $13,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Dexcom Inc Transaction History